Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    (lymphoma [CONDITION] OR CLL [CONDITION]) AND DT2219ARL [TREATMENT][TREATMENT]
Show Display Options
Rank Status Study
1 Completed DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma
Conditions: Leukemia;   Lymphoma
Intervention: Biological: DT2219ARL
2 Recruiting HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma
Conditions: Refractory B-Lineage Leukemia;   Relapsed B-Lineage Leukemia;   Refractory B-Lineage Lymphoma;   Relapsed B-Lineage Lymphoma
Intervention: Biological: DT2219ARL

Study has passed its completion date and status has not been verified in more than two years.